Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 19 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

6%

1 of 18 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (1)
Early P 1 (2)
P 1 (13)
P 2 (1)

Trial Status

Completed18
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT05519514Phase 1Completed

Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects

NCT02922933Phase 1Completed

A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects

NCT02922946Phase 1Completed

Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat

NCT01437033Completed

Breath Test for Chemicals (Volatile Organic Compounds)

NCT03277456Early Phase 1CompletedPrimary

A Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1

NCT01776437Phase 1CompletedPrimary

Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers

NCT03093506Early Phase 1CompletedPrimary

Effects of Micro-dose and Low-dose Recombinant Human Erythropoietin on Mitochondrial Function and Cognitive Performance

NCT01452425Phase 1CompletedPrimary

In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome

NCT01618877Phase 1CompletedPrimary

A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy Volunteers

NCT01618903Phase 1CompletedPrimary

An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese

NCT01464385Phase 2CompletedPrimary

Nutrition Beverage Tolerance Study

NCT01468714Phase 1CompletedPrimary

A Study To Estimate The Effect Of Ketoconazole On The Pharmacokinetics Of Pf-04937319 In Healthy Subjects

NCT01445860Phase 1CompletedPrimary

Drug-Drug Interaction Study Of Effect Of PF-03882845 On Simvastatin Pharmacokinetics

NCT00744809Phase 1CompletedPrimary

TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart Conduction and Heart Rhythm) in Healthy Volunteers.

NCT00752466Phase 1CompletedPrimary

A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separately

NCT00254449Phase 1CompletedPrimary

Effect of NGX-4010 on ENFD and Sensory Function

NCT00743977Not ApplicableUnknownPrimary

Bioequivalence of Phenazopyridine HCl in Healthy Volunteers

NCT00526968Phase 1CompletedPrimary

The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function

NCT00166933CompletedPrimary

Minimal Erythema Dose of UV-B in Normal Population of Taiwan

Showing all 19 trials

Research Network

Activity Timeline